Alpha‐synuclein is implicated in PD risk and researchers have demonstrated that α‐synuclein promotes microglia antigen processing and presentation, CD4 T‐cell activation, and proliferation in vitro and in vivo.45 The gene discussed is CD4; the disease is Parkinson disease.